跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Caltrate 600 mg Tablets - TGA Drug Approval Details
Approvals
/
TGA
/
Caltrate 600 mg Tablets
Approved
STANDARD
Caltrate 600 mg Tablets
Haleon Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d2b5d477ba3d3963
Company
Haleon Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
d2b5d477ba3d3963
Product Name
Caltrate 600 mg Tablets
Artg Id
404939
Artg Name
Caltrate 600 mg Tablets
Sponsor
Haleon Australia Pty Ltd
Company Detail Path
/organization/haleon-australia-pty-ltd
Artg Date
2023-02-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d2b5d477ba3d3963
Type
Standard
Back to TGA Approvals